One of the most common treatments for obstructive sleep apnea is continuous positive airway pressure (CPAP) applied by ... but there are also bundles for ResMed AirSense 10 ($339), Fisher ...
Q2 2025 Management View CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, ...
UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results